Toni Choueiri

Dana-Farber Cancer Inst

$2,782,193

Attributed

$5,609,717

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.4M · FY2015–25

$2M$1.5M$1M$500K$0

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$5,609,717 · 6

By mechanism

R01$4,199,121 · 2

R21$1,315,625 · 3

P30$94,971 · 1

Top collaborators

Most similar at Dana-Farber Cancer Inst

Same institution · by research overlap

Tracy T Batchelor$27,819,477
Bruce E. Johnson$13,594,149
Sabina Signoretti$9,867,905
Tao Zou$1,044,145
Donald W. Kufe$50,160,456

Others in their field

Top investigators on “Tumor”

David Heimbrook · Leidos Biomedical Research, Inc.$636,492,067
Leonard Freedman · Leidos Biomedical Research, Inc.$360,535,780
Gregory H Reaman · National Childhood Cancer Foundation$208,276,509
Richard K. Wilson · Washington University$203,917,615
Norman Wolmark · Nsabp Foundation, Inc.$177,323,696
Ronald T Mitsuyasu · University Of California Los Angeles$138,361,819

Research focus

TumorResponsePathway InteractionsClinical TrialsRenal Cell CarcinomaResistanceRandomizedMalignant NeoplasmsVascular Endothelial Growth FactorsToxic EffectClear Cell Renal Cell CarcinomaImmune Checkpoint InhibitorPhenotypeSpecimenImmunePhase Iii TrialMutationBiological MarkersMetastatic Renal Cell CancerPersonalized MedicineCellsGenesRenal CarcinomaTumor Microenvironment